Amica Mutual Insurance Co. cut its stake in shares of Amgen (NASDAQ:AMGN) by 15.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 35,770 shares of the medical research companys stock …
The biotech sector was in focus last week with Protagonist's stock plunging on news of discontinuation of a phase IIb study and Verona Pharma stock surging on positive top-line data from COPD study among others.
Even though Amgen, Inc. (NASDAQ:AMGN) stock has one of the best-performing charts I’ve seen, it doesn’t get the respect it deserves. From a valuation perspective, it sells at a sizable discount to its competitors. Its price-earnings …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
They didn’t disappoint on the report, but perception is what counts for the short term. AMGN Stock: Buy the Dip in Amgen, Inc. While Wall Street Fears It Source: Richard Masoner via Flickr No, I am not here to share a bearish trade. I like to …